Evotec’s Panomics Target Discovery service offers cutting-edge computational solutions and analyses for mining multi-Omics data from patient cohorts and screens. In this context, a target can refer to an individual gene, protein, mechanism, or mode of action.
Curated high-quality, proprietary and public data is the cornerstone of our service, ensuring that our analyses are accurate, reproducible and reliable. Our services are seamlessly integrated into Evotec’s PanOmics platform, encompassing multi-analysis automation, data generation, and safety prediction.
By leveraging multi-Omics data, we can provide a comprehensive view of biological systems, which is crucial for understanding complex biological mechanisms and identifying potential targets. True multi-Omics means for us the scale of large clinical cohorts or screens, spanning from Genomics, Transcriptomics, Proteomics to Metabolomics. This is coupled with the depth and detail provided by high-resolution sequencing technologies, such as single-cell and spatial sequencing.
Our approach combines biological and computational expertise, allowing us to deliver insights that are both deep and actionable. This integration is essential for making sense of the vast amounts of data generated in modern drug discovery and for translating these insights into real-world applications.
For patient omics, we deliver on:
- Understanding molecular disease mechanisms
- Identifying the right target for an indication
- Finding the right indication for a target
- Triaging a list of targets
- Genetic validation
For screening omics, we deliver on:
- Ranking hits based on omics signatures
- Deconvoluting modes of action
- Triaging targets from phenotypic screens
Our Understanding & Mission for Target ID
- Evotec’s Modular Target Identification System: PanOmics TargetID Framework >
- Mining Omics Data for Drug Discovery >
- Meet Our Team >
